CALCIUM-CHANNEL ANTAGONISTS

被引:0
作者
GEMMILL, J
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:638 / 640
页数:3
相关论文
共 50 条
[41]   Conflict of interest in the debate over calcium-channel antagonists [J].
Opie, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (23) :1696-1697
[42]   PHARMACOKINETIC INTERACTIONS WITH CALCIUM-CHANNEL ANTAGONISTS .1. [J].
SCHLANZ, KD ;
MYRE, SA ;
BOTTORFF, MB .
CLINICAL PHARMACOKINETICS, 1991, 21 (05) :344-356
[43]   CENTRAL CARDIOVASCULAR ACTIONS OF CALCIUM-CHANNEL ANTAGONISTS IN DOGS [J].
DAMASEMICHEL, C ;
MONTASTRUC, JL ;
MONTASTRUC, P .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, VOL 3 SUPPL: CENTRAL EFFECTS OF CALCIUM ANTAGONISTS, 1989, :S57-S64
[44]   POTENTIATION OF DEPOLARIZING NEUROMUSCULAR BLOCKADE BY CALCIUM-CHANNEL ANTAGONISTS [J].
MCISAAC, R ;
ALLEN, M .
FEDERATION PROCEEDINGS, 1985, 44 (05) :1388-1388
[45]   CALCIUM-CHANNEL ANTAGONISTS DECREASE THE ETHANOL WITHDRAWAL SYNDROME [J].
LITTLE, HJ ;
DOLIN, SJ ;
HALSEY, MJ .
LIFE SCIENCES, 1986, 39 (22) :2059-2065
[46]   Conflict of interest in the debate over calcium-channel antagonists [J].
Stelfox, HT ;
Chua, G ;
O'Rourke, K ;
Detsky, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :101-106
[47]   CENTRAL CARDIOVASCULAR ACTIONS OF CALCIUM-CHANNEL ANTAGONISTS IN DOGS [J].
DAMASEMICHEL, C ;
MONTASTRUC, JL ;
MONTASTRUC, P .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1989, 3 :S57-S64
[48]   Comment: mibefradil, a new class of calcium-channel antagonists [J].
Otterman, S .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (12) :1372-1372
[49]   HORMONAL AND METABOLIC EFFECTS OF CALCIUM-CHANNEL ANTAGONISTS IN MAN [J].
SCHOEN, RE ;
FRISHMAN, WH ;
SHAMOON, H .
AMERICAN JOURNAL OF MEDICINE, 1988, 84 (03) :492-504
[50]   COMPARATIVE POTENCIES OF CALCIUM-CHANNEL ANTAGONISTS AND ANTISCHIZOPHRENIC DRUGS ON CENTRAL AND PERIPHERAL CALCIUM-CHANNEL BINDING-SITES [J].
QUIRION, R ;
LAFAILLE, F ;
NAIR, NPV .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (06) :437-440